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ABSTRACT
The 3Rs –Replacement, Reduction and Refinement – are embedded
into the legislation and guidelines governing the ethics of animal use
in experiments. Here, we consider the advantages of adopting key
aspects of the 3Rs into experimental biology, represented mainly by
the fields of animal behaviour, neurobiology, physiology, toxicology
and biomechanics. Replacing protected animals with less sentient
forms or species, cells, tissues or computer modelling approaches
has been broadly successful. However, many studies investigate
specific models that exhibit a particular adaptation, or a species that is
a target for conservation, such that their replacement is inappropriate.
Regardless of the species used, refining procedures to ensure the
health and well-being of animals prior to and during experiments is
crucial for the integrity of the results and legitimacy of the science.
Although the concepts of health and welfare are developed for model
organisms, relatively little is known regarding non-traditional species
that may be more ecologically relevant. Studies should reduce the
number of experimental animals by employing the minimum suitable
sample size. This is often calculated using power analyses, which is
associated with making statistical inferences based on the P-value,
yet P-values often leave scientists on shaky ground. We endorse
focusing on effect sizes accompanied by confidence intervals as a
more appropriate means of interpreting data; in turn, sample size
could be calculated based on effect size precision. Ultimately, the
appropriate employment of the 3Rs principles in experimental biology
empowers scientists in justifying their research, and results in higher-
quality science.
KEY WORDS: Animal welfare, Environmental enrichment,
Replacement, Reduction, Refinement, Toxicology
Introduction
Animal research is essential for the advancement of new
technologies and medicines crucial to improving human and
animal health. It is also vital for our understanding of
fundamental animal biology, as well as essential areas of applied
animal science, such as how animals function in the face of climate
change or anthropogenic disturbance. Further, studies exploring
animal health and welfare enable us to manage captive animals more
effectively, and prevent poor welfare that leads to disease. Against
this backdrop of necessary animal research, scientists are
increasingly asked to justify their experimental approaches when
using protected animals (Box 1). This is partly driven by demands
from the general public that the use of animals in research is moral
and ethically justifiable. A recent poll in the USA demonstrated that
50% of the public were opposed to the use of animals in research
(http://www.pewinternet.org/2015/01/29/public-and-scientists-
views-on-science-and-society/). In 2015, nine European countries
presented a petition to the European Commission (EC) to ban
animal research. However, the EC opposed this movement, but
responded by stating that ethical justification and adoption of the
3Rs (Replacement, Reduction and Refinement) is a must for
experimental studies (European Commission, 2015). Of course, it is
in scientists’ interest to adopt an ethical and humane approach to
husbandry and experimental design, as healthy animals produce
robust, reliable results, underlying valid scientific outputs. For
example, improved husbandry and handling of rodents reduces
stress, and this leads to less-variable data and more meaningful
results (Hurst and West, 2010; Singhal et al., 2014). Embedding the
3Rs principles into scientific planning and execution therefore
directly benefits data quality.
The 3Rs concept was first developed by Russell and Burch
(1959) and has become rooted in legislation and guidelines
concerning animal experimentation in many countries (Fig. 1).
Replacement involves the adoption of alternatives to protected
animals – such alternatives may be nonprotected species or
immature forms; cell lines or cultured tissues; mathematical
modelling of existing data sets or conceptual data; or the use of
humans, their tissues or their cells (with permission). Reduction
concerns minimising the number of animals used to effectively
achieve the goals of an experiment. Refinement involves either
reducing the invasiveness of a technique or improving animal
welfare and health during scientific studies. This can be achieved
through better assessment of the animal’s state or improved
husbandry and housing. Many funding bodies in the UK and
Europe now have dedicated application sections on each of the 3Rs
that must be completed, thus requiring justification of the use of
protected animals. In this Commentary, we discuss current
knowledge and recent developments in the 3Rs relevant to the
field of experimental animal biology. Our views are fuelled by a
recent symposium funded by the Society for Experimental Biology
(SEB) and co-funded by the Association for the Study of Animal
Behaviour (ASAB), held in London in 2016 (Knight, 2016).
Replacement
Replacement in a comparative physiology context
Studying physiological adaptation or the response of vulnerable
species to environmental perturbations is at the core of comparative
and conservation physiology. Krogh’s principle states that ‘for such
a large number of problems there will be some animal of choice, or a
few such animals, on which it can be most conveniently studied’.
Thus, often in the comparative and conservation disciplines,
animals cannot be easily replaced, and reduction and refinement
are more realistic ethical strategies. However, the evolutionary
1Institute of Integrative Biology, Department of Evolution, Ecology and Behaviour,
University of Liverpool, The BioScience Building, Liverpool L69 7ZB, UK.
2Department of Life Sciences, University of Roehampton, London SW15 4JD, UK.
3University of Suffolk, Faculty of Health Sciences and Technology, James Hehir
Building, Neptune Quay, Ipswich IP4 1QJ, Suffolk, UK.
*Author for correspondence (lsneddon@liverpool.ac.uk)
L.U.S., 0000-0001-9787-3948
3007
© 2017. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2017) 220, 3007-3016 doi:10.1242/jeb.147058
Jo
u
rn
al
o
f
Ex
p
er
im
en
ta
lB
io
lo
g
y
conservation of physiological traits throughout the eukaryotes
means that alternative non-vertebrate organisms can provide
valuable information where processes are shared with model
organisms, enabling experimental biologists to embrace the
replacement approach. For example, the cellular responses of the
soil-dwelling amoebaDichtyostelium can be used as a rapid screen for
the effects of medicinal products (Otto et al., 2016). As another
example, the simplified neuronal network of the pond snail Lymnaea
stagnalis can be used to study the neurobiological processes involved
in decision making and motivational state (Crossley et al., 2016), as
well as the effects of stressors onmemory formation (Lukowiak et al.,
2014). In addition, ex vivo systems, organoid cell cultures and
immortalised cell lines are often utilised and, although they cannot
replace the complex interactions between tissues in intact vertebrates,
they can provide insight when investigating intra- and inter-cellular
biological processes or tissue-level responses. The key is to find the
right non-vertebrate model organism or in vitro system to answer the
question of interest – a concept that will be very familiar to a
comparative physiologist audience.
Factors driving replacement research
Recent advancements in replacement approaches within
experimental biology have occurred in identifying alternatives to
the use of vertebrates in regulatory tests – tests that are required by
law as part of any chemical’s risk assessment, such as OECD Test
No. 305 (Bioaccumulation in Fish: Aqueous and Dietary Exposure;
OECD, 2013) and OECD Test No. 203 (Fish, Acute Toxicity Test;
OECD, 1992) (Lillicrap et al., 2016) for aquatic environmental risk
assessment. For example, within Europe, the regulations concerning
the Registration, Evaluation, Authorisation and restriction of
Chemicals (REACH) have resulted in many thousands of
chemicals requiring further animal testing. Though the European
Union (EU) did not ban animal testing as part of REACH, animal
welfare legislation requires the incorporation of the 3Rs principles.
This has led to a strong impetus for regulatory authorities to accept
replacement test systems as part of risk assessment evaluation
(Burden et al., 2016). Acceptance requires a rigorous scientific
understanding about whether such alternatives adequately reflect
physiological processes observed in intact adult fish.
Suitable replacements
Embryonic and young forms
The young forms of many species are not considered to suffer. Thus,
the UKAnimals (Scientific Procedures) Act 1986 (https://www.gov.
uk/government/publications/consolidated-version-of-aspa-1986) and
European Directive 2010/63 (http://eur-lex.europa.eu/legal-content/
EN/TXT/?uri=CELEX:32010L0063) specifies that fish become a
protected animal once they are capable of independent feeding [e.g.
zebrafish after 120 h post-fertilization (120 hpf) at 28°C; Strähle
et al., 2012]. However, this is not the case for all countries (Box 1).
This threshold is based upon the concept that, before this stage, fish
are not fully developed and are unable to experience external stimuli,
meaning there is no obligation to report the number of fish embryos
used. But recent studies show that 120-hpf larval zebrafish respond to
noxious stimuli, and that this is ameliorated by administration of pain-
relieving drugs (Lopez Luna et al., 2017a,b). From a regulatory
perspective, the fish embryo toxicity (FET) test, which lasts for 96 hpf
for zebrafish (Henn and Braunbeck, 2011), correlates well with adult
acute toxicity (Lammer et al., 2009; Scholz et al., 2014), and the
OECD have approved OECD Test No. 236 [Fish Embryo Acute
Toxicity (FET) Test] guidelines (Busquets et al., 2014).
In basic research, embryos, including those from chickens, have
been used extensively to study the development and functioning of
organs within the context of a whole organism (e.g. Tazawa et al.,
2002). Zebrafish embryos are now used for many basic
physiological and behavioural studies; for example, sophisticated
video imaging packages can be used to record their movement in
response to chemical exposure (e.g. Nüßer et al., 2016), translucent
fish embryos provide an ideal model to study cardiovascular
function (Incardona and Scholz, 2016; Yozzo et al., 2013), and
genetic manipulation has enabled the study of the functional
regulation of ionoregulation (Cruz et al., 2013; Guh et al., 2015).
Cell lines and organoid cultures
The EU’s decision to ban animal testing for cosmetics ingredients
(EU1223/2009) provided the momentum to develop alternative
mammalian in vitro models to identify chemicals that pose a
health risk. In addition, there is a long history of the development of
fish cell lines from a variety of tissues and organisms (Bols et al.,
2005). For example, the cell line derived from the gills of rainbow
trout (RTgill-W1) (Bols et al., 1994) is promising as a replacement
for OECD Test No. 203 (OECD, 1992; Tanneberger et al., 2013;
Lillicrap et al., 2016) and for chronic toxicity tests. But further
basic mechanistic understanding of how cell growth in culture
correlates with somatic growth in a whole fish is necessary for
in vitro to in vivo extrapolation (Stadnicka-Michalak et al., 2015).
Extensive research has gone into mammalian tissue and stem cell-
derived organoid cultures for disease and drug development
research (Liu et al., 2016; Muthuswamy, 2017). The time it takes
to develop these types of in vitromodel may make them unsuited to
comparative physiological studies, but they are of interest for basic
research because these systems better replicate in situ tissue
physiology than do 2D cell cultures.
A further development is the potential replacement of OECD Test
No. 305 (OECD, 2013), which has led to technical advancements
in fish in vitro organoid cultures (Baron et al., 2012; Schnell et al.,
2016). Data on the basic characteristics of chemical uptake,
metabolism and excretion by these organoid cultures provide the
Box 1. Which animals are protected under the legislation
of selected countries?
Globally, legislation differs between countries and geographical regions.
Either all animals used in research are protected (specific species or
ages are not prescribed) or the legislation identifies which animals at
what stage of development are included.
Country or region Protected animals
Australia Vertebrates of all developmental stages
Cephalopods of all developmental stages
Brazil All animals
China All animals
Europe Adult vertebrates
Mammalian, bird and reptile fetuses in last third of
development
Amphibians and fish at the free-feeding stage
Cephalopods at the free-feeding stage
India All animals
South Africa All vertebrates including eggs, fetuses and
embryos
Cephalopods
Decapods
USA Warm-blooded vertebrates except farm animals
used in food and fibre research, rats of the genus
Rattus and mice of the genus Mus
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scientific rigor that supports their use in alternative testing
procedures for bioconcentration studies. For example, a primary
fish gill culture technique has been developed by which two fish
(subject only to humane killing) can be used to produce between 48
and 72 cell culture inserts: harvesting of cells for primary culture in
the UK is not defined as a procedure, so this approach replaces the
use of animals (Schnell et al., 2016). The system has been used to
study branchial physiological processes, such as ammonia excretion
and endocrine control of epithelial tight junction formation (see
Bury et al., 2014). The liver is the main site of metabolism and
excretion, and a number of ex vivo and in vitro methods (e.g. liver
slices, primary hepatocytes, S9 fraction and cell cultures) have been
deployed to estimate the ability of the liver to metabolise
compounds (see Weisbrod et al., 2009). Recent advances in liver
organoid cell culture techniques have led to the generation of 3D
spheroidal hepatocytes (Uchea et al., 2015; Baron et al., 2012)
that better represent the metabolic capabilities of the intact liver
(Baron et al., 2017). Encouragingly, there are a number of studies
that extrapolate the hepatocyte in vitro biotransformation data to
in vivo scenarios (Nichols et al., 2006, 2007; Cowan-Ellsberry et al.,
2008), allowing derivation of bioconcentration factors (Nichols
et al., 2013).
High-throughput FET or in vitro screens are being used as part
of the Adverse Outcome Pathways (AOPs) conceptual framework
to identify molecular initiating events (MiE) induced by a
compound (Ankley et al., 2010; Wittwehr, et al., 2017). AOPs
aim to use empirical mechanistic data at lower levels of biological
organisation (e.g. cells) to predict higher level effects (e.g. whole-
organism toxicity). MiE identification can uncover chemicals of
unknown toxic action or off-target effects (Villeneuve et al.,
2014). Ultimately, it is envisaged that the AOP concept can lead to
computer-based predictive models to assist environmental risk
assessment (Wittwehr et al., 2017), replacing many, if not all,
animals used in regulatory procedures. The AOP concept is a
wonderful example of how toxicology and physiology are
intertwined. The wealth of data on the downstream effects of
stimulating a receptor within a cell, whether by a synthetic or a
natural chemical, will potentially aid the identification of
regulatory mechanisms and feedback control of physiological
processes.
Ethical animal
experimentation
Justify study
Is the study beneficial to humans or animals? Benefits can be
medical, veterinary, economic, biological or educational.
Replacement
Necessity for using whole animals? Can an immature form or
invertebrate* model be used? Human volunteers, human cells
and tissues, or animal cell and tissue preparations?
Is the model relevant?  
Mathematical or computational modelling of existing data sets
rather than a new study using animals? 
Reduction
Is the sample size just large enough to give sufficiently
informative results, avoiding the use of too many animals?
Will the outcomes be published and/or included in a future
meta-analysis? 
Refinement
Husbandry and housing – are animals kept in good health?
Will health be appropriately monitored and action taken
quickly to improve welfare before and during experiments?
Are the least invasive techniques being employed to promote
good welfare during experiments?
Where procedures compromise welfare, are protocols in place
to improve this, e.g. pain relief?
Publish
Will it generate novel knowledge or have applied relevance?
Has the design been logged prior to commencing the
experiment?
Is the experimental design appropriate to address the research
question, e.g. blinding, randomisation?
Fig. 1. Ethical thinking when planning animal experiments: from conceiving an experiment and applying the 3Rs to publication. The figure shows a
diagrammatic representation of the major ethical concepts and key questions that scientists must address under the traditional view of the 3Rs – Replacement,
Reduction and Refinement – to justify the use of animals in experimentation, from planning the programme of work through to publication. *Except cephalopods,
which are protected animals in Australia, Europe and South Africa, as listed in Box 1.
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Reduction
‘Reduction’ proposes that researchers reduce the number of
experimental animals used such that just enough data and no
more are obtained to give sufficiently informative results.
Experimental designs that incorporate stronger perturbations or
support greater measurement precision improve the signal-to-noise
ratio of the data analysis (see Halsey, 2007), which enables the
sample size to be reduced. Put simply, cleaner and clearer
experiments require fewer experimental animals for the analysis to
be robust. Authors such as McClelland (2000), Eng (2003) and de
Boo and Hendriksen (2005) suggest various avenues for improving
measurement precision, including: (1) using more reliable
measures, repeating measurements, using experienced staff and
well-honed experimental procedures; (2) incorporating measures
of concomitant variables (such as body mass) to account for
measurable variability; (3) experimentally reducing variability, e.g.
by working with one age group or sex (the latter pertains to both
study animal and researcher; Sorge et al., 2014); however, this
reduces the generalisability of the findings (Würbel, 2000), and thus
has been disallowed by the National Institutes of Health in the USA;
(4) increasing the variance in the predictor variable(s); for example,
including animals with a greater age range if studying correlates of
senescence; (5) using subjects as their own controls (e.g. testing each
animal after a saline injection as well as a hormone injection).
However, we argue that there is an over-arching research problem that
typically supersedes tweaksmade to experimental designs – the focus
on the ubiquitous P-value when interpreting data analyses.
Regardless of the experimental design, because of some intrinsic
frailties of P-value-based data analysis, such studies will usually have
employed a sample size too small for robust conclusions to be made.
Reduction… in the use of the P-value for data interpretation
Typically, the number of animals included in an experiment is
determined using statistical power analysis to calculate the sample
size required for an estimated probability of correctly rejecting the
null hypothesis. Statistical power of 80% is the norm (Cohen, 1988),
which means that when the null hypothesis being tested is false, a
statistically significant result will be reported 80% of the time. The
number of animals necessary to achieve 80% power in a well-
designed experiment is deemed ‘required’ and is thus ethically
acceptable according to the 3Rs philosophy. Power analysis is
intimately tied to the P-value, as the latter is used to decide whether
the null hypothesis is rejected or not (and thus whether a finding is
deemed ‘significant’).
Recently, it has become evident that many scientific findings are
not reproducible (Baker, 2016; Open Science Collaboration, 2015),
shaking the pursuit of science to its core (Economist, 2013; Freedman
et al., 2015; Mobley et al., 2013; Ioannidis, 2005). To conduct a study
on animals that is not reproducible is fundamentally counter to the 3Rs
principle, indicating that animals have been used in fruitless and
even misleading experiments (Button et al., 2013). Many authors
have discussed how to combat irreproducibility (Freedman et al.,
2015; Ioannidis et al., 2015; McNutt, 2014; Nosek et al.,
2015; Woolston, 2014; http://validation.scienceexchange.com/
#/reproducibility-initiative). While only a few publications have
targeted the P-value as a potential culprit, these papers have
compellingly argued that over-reliance on P-values for data
interpretation is helping to drive irreproducibility (Colquhoun, 2014;
Cumming, 2008; Halsey et al., 2015; Nuzzo, 2014; although other
factors, such as lack of homogeneity in protocols, can contribute).
Two arguments are made. First, interpretation of data based on
P-values will often produce misleading conclusions owing to the
false discovery rate, which is the probability of calculating a P-
value sufficiently low to claim ‘significance’ when in fact the null
hypothesis is true (Colquhoun, 2014). Assuming P-values <0.05
are those considered ‘significant’, and that the proportion of
studies conducted where the null hypothesis is false is 10%, the
false discovery rate is at least 36% according to Colquhoun (2014)
and Sellke et al. (2001) (although it could be less in research fields
where scientists conduct the experiments they anticipate are likely
to return ‘significant’ results; Wacholder et al., 2004). Second,
models have highlighted that P-values typically vary dramatically
between replicates of a study, and this ‘fickleness’ in P-values is
present even when statistical power is quite high, e.g. 80%
(Cumming, 2008; Halsey et al., 2015).
In the biological disciplines, average statistical power, including
in fields such as neuroscience (Button et al., 2013; Macleod et al.,
2009) and behavioural ecology (Jennions and Møller, 2003), is
consistently less than 50% and often considerably lower (Smith
et al., 2011). Such low power exacerbates the problem of false
discoveries and the inherent fickleness of P-values. Simply put,
when a study reports a P-value indicating strong evidence against
the null hypothesis, there is every chance that a replication of that
study would report a P-value indicating much less evidence against
the null hypothesis (and vice versa). Furthermore, studies that do
yield significant results tend to exaggerate the true effect size, and
this is exacerbated when statistical power is low (Button et al., 2013;
Halsey et al., 2015). Consequently, the interpretation of one-off
experiments based on the P-value may explain why so many studies
are irreproducible (Halsey et al., 2015).
There are further valid reasons to question the usefulness of
P-values for data interpretation (Cohen, 1994; Tressoldi et al., 2013).
Of particular relevance is that significance testing of the null
hypothesis only allows us to ask a very limited question about our
data, simply ‘is there or isn’t there?’. For example, ‘is there a
difference in metabolic rates between two mouse strains?’ or ‘is there
a relationship between metabolic rate and risk-taking behaviour?’.
Given a large enough study, we can always find a difference, or a
relationship, to some degree (Cohen, 1994; Loftus, 1993), and so
answering these questions tells us very little about our data.
Once these sobering facts about the P-value have sunk in, the
only conclusion open to us is to greatly reduce, or even discard, our
use of P-values in statistical analyses. Although P-values are
entrenched within the research culture of experimental biology,
when animal health and welfare are at stake it is surely unethical to
continue using an inadequate statistical index for data interpretation.
In turn, the use of power analysis to calculate the necessary number
of experimental animals becomes questionable.
What alternatives do we have?
There are several alternatives available, such as Bayesian analysis
and the Akaike Information Criterion, although nomethod is perfect
(Ellison et al., 2014). We suggest that instead of focusing on the
standard approach of ‘is there or isn’t there?’, it is more illuminating
to ask ‘how big is the difference?’ or ‘how strong is the
relationship?’, coupled with the question ‘how precise is
the estimate of the magnitude of the difference or relationship?’.
The answers to these two questions not only tell us whether there is a
difference or a relationship but also inform us of its (estimated)
magnitude coupled with how precise that estimate is likely to be; all
in all, a much better use of experimental animals. The most
straightforward way to analyse our data in order to answer these two
questions is first to calculate the effect size – the size of the
difference between conditions or the strength of the correlation
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between two variables. Second, because our experiment only
estimates rather than measures the population effect size, we should
also provide the confidence intervals for that estimate, to indicate
how precisely the effect is known (Cumming, 2008; Halsey et al.,
2015; Johnson, 1999; Nakagawa and Cuthill, 2007).
More is less
When basing data interpretation on effect size estimates and their
precision, the number of experimental animals required should
relate to how precisely we need our sample to represent the
population. ‘Planning for precision’ calculates the sample size
required for the effect size needed in order to provide a defined
degree of precision, based on the predicted effect size and variance
within the data (Maxwell et al., 2008). Currently, few studies take
this approach; when presented, 95% confidence intervals are often
large, showing poor precision – a fact that may explain the omission
of confidence intervals from many figures. But it is important that
we are aware of the level of precision (or otherwise) in our
experimental results (rather than hiding it behind a P-value;
Cumming, 2008); if necessary we should adjust our sample size
accordingly. Designing experiments around precision rather than
power analysis is likely to increase experimental animal numbers.
However, if the results are more meaningful, then this should reduce
the number of experiment repetitions needed, hence reducing
experimental animal numbers in the long run.
Perhaps the strongest argument for analyses based on effect sizes
combined with confidence intervals is that where multiple studies
on a particular question have been published and this information
included, it can then be combined in a meta-analysis, enabling us to
home in on the statistical truth (e.g. Sena et al., 2010). Typically, the
confidence intervals around an effect size calculated from meta-
analysis are much smaller than those of the individual studies (Cohn
and Becker, 2003), thus giving a much clearer picture about the true,
population-level effect size (Fig. 2). Indeed, sample sizes required to
detect effect sizes with suitable precision are often prohibitive or
deemed unethical for individual researchers, necessitating future
meta-analyses (Maxwell et al., 2008). And meta-analyses are
efficient on experimental animal numbers. First, where a meta-
analysis is undertaken solely on previously published data, it
represents an experiment-free study; the ultimate in 3Rs Reduction.
Second, where multiple studies of a similar nature are conducted on
a relatively intractable research question (Nature Magazine, 2016),
within as well as across publications, meta-analyses give a good
indication of when such replicate experiments are no longer
necessary (Fig. 2). However, the Achilles heel of the meta-
analysis is the ‘file drawer phenomenon’. Data on animal
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Fig. 2. Cumulative meta-analysis of the efficacy of lytic
treatments (e.g. tissue plasminogen activator) in
thrombotic animal models of stroke. The data have been
adapted to illustrate key points explained and discussed in
this article. Studies are added to the cumulative meta-
analysis in order of their publication date. The greater the
value on the x-axis, the greater the positive effect of the
treatment. Treatment improves outcome; however, the
estimate of efficacy (effect size) decreased as more data
became available. This often happens, because studies are
typically underpowered and therefore, when statistically
significant, tend to overestimate the true effect size (Halsey
et al., 2015). Note also the considerable size of the 95%
confidence intervals (thin horizontal bars) for the first study
and even once the first few studies are combined; this is
common and demonstrates the lack of precision that
individual studies often provide about the true (population)
effect size, but is not apparent when focusing on the
associated P-value. Indeed, focusing on the P-value of
each study to synthesise the findings would return a
confused conclusion, as while many of the studies report a
statistically significant effect of the treatment (black data
points and 95% confidence intervals indicate that the latest
study added to the meta-analysis was statistically
significant), many of the studies indicate no treatment
efficacy (blue). In contrast, focusing on the effect size and
95% confidence intervals of each study shows a relatively
consistent pattern of evidence of treatment efficacy (as
illustrated), and estimated accuracy of the degree of
treatment efficacy steadily improves as more studies are
combined into the meta-analysis. The thick horizontal line
shows a suggested approximate date at which the efficacy
of the treatment was well known and further studies were
unlikely to substantially refine this. Although studies
published subsequent to 2001/2002 probably included
other valuable experiments and/or analyses, this figure
illustrates that meta-analyses can inform about when further
study of a particular treatment or phenomenon would be
unproductive. Heeding such information would reduce the
number of animals used in experimental research. This
figure was modified from Sena et al. (2010), with
permission.
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experiments are often filed away and not published if found to be
‘non-significant’ (Dwan et al., 2013) – another example of the
need to remove the focus on the P-value. Yet, the results of all
robust and relevant studies provide invaluable grist to the mill for
a future meta-analysis, regardless of their supposed ‘interest’, and
meta-analyses often highlight approximate agreements between
multiple studies that appear contradictory when viewed as
providing either ‘significant’ or ‘non-significant’ findings.
Indeed, filing away uninteresting data skews the distribution of
published data and distorts the truth, which in the long run will
lead to a greater overall number of animals being subjected to
experiments. It is therefore essential for 3Rs Reduction, and for
the pursuit of science in general, that all valid experimental data
are published. Fortunately, there are progressively more journals
that explicitly judge whether a submission is suitable for
publication on merit alone without consideration of impact. And
for those researchers who insist on P-value-based interpretations,
the revised version of the European Code of Conduct for Research
Integrity states that non-significant results should be treated as
valid findings worthy of publication (Wissenschaftsstiftung,
2017; Box 2); a standard that the EU’s Horizon 2020 programme
now expects its recipients to abide by.
Refinement
Refinement is an integral component of improving laboratory
animal welfare, which is vital for healthy biological functioning
and a normal behavioural repertoire. Therefore, refining
procedures to reduce their invasiveness or the degree of stress
they cause and perfecting housing and husbandry should be the
goal of any scientist. However, some animal groups have received
relatively little attention in this area, resulting in less-developed
tools or knowledge to assess their health and welfare (e.g. pain
assessment is highly developed for mammals compared with
other animal groups; Sneddon et al., 2014; Sneddon, 2015).
Additionally, good husbandry practices improve animal wellbeing
and the reliability of experimental results; thus, it is important to
know what different species require in their environment in order
to maintain their health and welfare. The necessity to develop
refinement recommendations and good laboratory practices for
both traditional and non-traditional species has driven this vibrant
research field.
Environmental enrichment
The EC Directive (2010; http://eur-lex.europa.eu/legal-content/EN/
TXT/?uri=CELEX:32010L0063) proposes that all protected
animals should have enriched environments in which to live.
Enrichment can involve physical objects that either make an
environment more complex (e.g. plastic plants, gravel substrate and
overhead cover in a fish tank; Pounder et al., 2016) or can be used by
the animals (e.g. perches in bird enclosures; Kalmar et al., 2010).
Alternatively, enrichment can involve appropriate social housing
(e.g. gregarious species not kept in isolation or territorial species
held in groups), apparatus to allow exercise (e.g. rodent running
wheel), nutritional enrichment (e.g. diversity of feeding regimens)
and sensory stimulation (visual, olfactory and aural; see Singhal
et al., 2014). Understanding the appropriate type of enrichment can
have tremendous benefits, reducing stress and the inter-individual
variation in behavioural and physiological variables (Singhal et al.,
2014). Preference testing can provide insight into what an animal
would choose, although this depends on the resources tested and so
caution should be applied. As an example of the effect that
refinement can have, it is known that zebrafish have relatively
smaller brains when reared in barren conditions compared with
enriched tanks (DePasquale et al., 2016), which might indicate
chronic sensory deprivation. This raises both ethical issues and
concerns about the veracity of neurobiological and behavioural
research conducted on such individuals. Indeed, zebrafish housed
for 7 months in barren tanks choose to interact with enrichment
when given the option (Schroeder et al., 2014). In addition, rainbow
trout housed in enriched tanks recover from stressors more quickly
(Pounder et al., 2016; Fig. 3A), and it is known that background
colour influences growth rates, physiological stress and behaviour
in Xenopus (Holmes et al., 2016; Fig. 3B). These studies can have
real impact upon husbandry protocols, which are essential for
guaranteeing the health of experimental animals.
Refining experimental procedures
Refinements to reduce the invasiveness of a procedure can be as
simple as improving the manner in which animals are handled.
Hurst andWest (2010) showed that handling mice by allowing them
to voluntarily sit in a cupped hand or enter a plastic tunnel reduced
anxiety and stress compared with the traditional method of picking
them up by the tail. Non-invasive imaging of molecular responses –
using techniques such as magnetic resonance imaging (MRI),
positron emission tomography (PET), single-positron emission
computed tomography, ultrasound and optical imaging
(bioluminescence and fluorescence) – circumvents the need to
humanely kill or biopsy animals for samples: imaging can be
performed in vivo and in real time, negating the necessity for
sampling groups of animals at various time points (O’Farrell et al.,
2013). These imaging techniques can monitor molecular and
cellular changes non-invasively in intact animals, although repeated
anaesthesia may be necessary and is likely to be stressful. These
approaches have facilitated significant advances in preclinical
research and, consequently, fewer animals are required, individuals
can be tracked over a longer time period and they are not subjected
to invasive, potentially painful, procedures (reviewed in O’Farrell
et al., 2013). Thus, there is scope for these non-invasive
technologies to be applied to a wide variety of contexts in
experimental animal biology, but there is a substantial economic
cost to employing imaging techniques.
Assessing welfare is key to ensuring that animals are healthy
before, during and after experiments where post-surgical care is
vital. Laboratory rodents have been well studied, and key
Box 2. P is for Publication
Many journals, funding bodies and reviewers like to see P-values and
power analyses. For this reason, experimenters might be concerned
about disadvantaging themselves if they become apostates of the P-
value doctrine. They might best be advised to continue reporting P-
values in their manuscripts but to shift the focus of interpretation onto
effect sizes. For project proposals, perhaps providing both a power
analysis and a plan for precision would be sensible. Below is a text
template that can be used for inclusion in the Methods section of
manuscripts to flag up that data interpretation will be based on effect
sizes, and to justify why, while reassuring that P-values will remain
present:
In the current article, the P-value is treated as a continuous variable
(Fisher, 1959; Boos and Stefanski, 2011), and because it is typically
highly imprecise it is considered to be only a tentative indication of the
strength of evidence for observed patterns in the data (Fisher, 1959;
Boos and Stefanski, 2011; Halsey et al., 2015). Primarily, patterns in the
data are interpreted from graphs of sample effect sizes and their
precision (quantified by 95% confidence intervals) (Lavine, 2014; Loftus,
1993).
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behavioural changes (Sneddon et al., 2014), as well as the more
recent grimace scales for rats, mice and rabbits, can be used to gauge
their pain levels (Langford et al., 2010; Sotocinal et al., 2011;
Keating et al., 2012; see http://www.nc3rs.org.uk/grimacescales for
scales). Extensions of the grimace scales have been applied to
horses (Dalla Costa et al., 2014), and are likely to be applicable to
other non-model mammals. Although non-mammalian animals are
less well studied, advances are being made. For example, fin
clipping of zebrafish, a routine procedure for genomic screening, is
normally conducted under anaesthesia, but analgesics are not
routinely applied. However, Schroeder and Sneddon (2017)
demonstrated substantial changes in behaviour after fin clipping
that were ameliorated by pain-relieving drugs (Fig. 3C). Rather than
injecting these relatively small fish, this study showed that adding
the drugs to the tank water effectively reduced pain, and this could
be extrapolated to other aquatic species. Further research is required
to develop robust indicators of welfare and health in a variety
of common laboratory models, as species can differ in their
expression of poor welfare. Automated monitoring of animal health
through non-invasive use of behavioural recording equipment
would be ideal (e.g. Rushen et al., 2012; www.noldus.com/projects/
sensewell).
Refinement for non-traditional experimental species
Although much is known about refinement in model organisms,
many experimental animal biologists use non-traditional species to
answer important and ecologically relevant physiological questions.
While refinements therefore need to be employed on a species-by-
species basis, general principles from model organisms should
make a good starting point from which welfare testing can begin. A
further confounding issue is that many experiments take place in the
field rather than in a laboratory. General principles of refinement can
be applied, with the capture, handling, tagging and sampling of
animals done in the most humane way. If invasive methods are
appropriate, ways to improve animal welfare and health can be
considered. Obviously, it can be difficult to assess health and
welfare if the animals are returned to their natural environment.
However, recapture studies (e.g. intraperitoneal tags, Gardner et al.,
2015; radio collars, Hopkins and Milton, 2016) and assessment of
subsequent breeding success (Phillips et al., 2003) can provide
some measure of survivorship. This is pertinent to understanding
how previous procedures may have affected the animals, given that
survival and reproduction can be affected by vulnerability to
predators, and by the ability to harvest resources and to cope with
intraspecific agonistic interactions.
Conclusions
Here, we have highlighted the benefits of adopting the 3Rs in
experimental biology: there are advantages for the quality of data
obtained, the robustness of the experimental design – including
statistical analyses – and the validity of the scientific outputs.
Adopting an ethical approach allows researchers to justify their
studies not only to legislators and ethics committees but also to
funding bodies and the public.
Refinement of both husbandry practices and experimental design
is an important aspect of the 3Rs. Developing optimal husbandry
and housing to ensure animal health and welfare and a means of
monitoring animal welfare before, during and after experiments is
paramount. Additionally, experimental design should be carefully
thought through and possibly logged in a database prior to the
study commencing. NC3Rs have developed an online tool – the
Experimental Design Assistant (https://eda.nc3rs.org.uk/) – to assist
researchers in developing their approach and to encourage
randomisation and blinding where possible to prevent bias.
Reproducibility and translatability of published studies have
recently come under scrutiny, and where problems are due to the
lack of full reporting of methods, many journals are tackling this via
adopting the ARRIVE guidelines, using a checklist to ensure that all
experimental details are provided to allow researchers to fully
replicate studies (http://www.nc3rs.org.uk/arrive-guidelines). To
encourage ethical thinking, we propose that all journals reporting
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Fig. 3. Examples of studies where refinement has proved to be beneficial
to thewelfare of the experimental animals. (A) Impact of enrichment (gravel,
plastic plant and overhead cover) on improving recovery rates in rainbow trout.
The graph shows the mean (±s.e.m.) recovery rate of the opercular beat rate
(OBR; beats min−1) post-treatment, in rainbow trout held in either enriched
(dark bars) or barren (light bars) environments. OBR recovery rate was
estimated for each individual fish by subtracting OBR at the time of recovery
fromOBR after either 1min of air emersion (stress) or deep-plane anaesthesia,
and dividing by the duration between time points (adapted from Pounder et al.,
2016, with kind permission from Elsevier). (B) Impact of background colour in
the tanks of Xenopus laevis, demonstrating that a white background results in
greater mean (±s.e.m.) body mass change (BMC) than a black background
(taken from Holmes et al., 2016, with kind permission from Elsevier). (C) The
use of pain-relieving drugs during recovery from fin clipping in zebrafish
ameliorates a reduction in activity. The graph shows the mean (±s.e.m.)
percentage change in activity level (number of swimming movements) 80 min
after tail fin clipping without analgesia (fin clip) or in conjunction with immersion
in lidocaine (5 mg l−1) in zebrafish (adapted from Schroeder and Sneddon,
2017, with kind permission from Elsevier).
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animal research could ask authors to include a section on ethical
justification of the study so that the 3Rs thought-process is clear
(some journals already do).
In terms of Reduction, there is a conflict between minimising the
number of animals used versus recent revelations that published results
may not be robust. How can a balance be struck between keeping
animal use as lowas possiblewhile including a large enough ‘N-value’
to ensure the study was worth doing? In debating this question, it is
counter-productive to couch it within the concept of power analysis
and, implicitly, the fickle P-value. We need to put the health and
welfare of animals ahead of our statistical traditions. In turn, when
designing experiments, we should plan for precision; we urge biology
journals to encourage this analysis rather than requesting power
analysis information as they do at present. For authors, we suggest
some draft text that could form the basis of a statement included in the
Methods section of a manuscript to highlight and justify the authors’
focus on statistical analyses other than the P-value (Box 2).
The biggest Reduction sin of all is not publishing our data –
animals have been used and zero knowledge accumulated. We must
strive to publish all results, however interesting or otherwise we
consider them to be, to make full use of the experimental animals
and to maximise the accuracy of future meta-analyses. Journals
publishing non-significant results and demanding high clarity are
invaluable in supporting this endeavour, ensuring the lives of all
animals used are respected.
Developments in the use of non-protected species and young
forms alongside the validation of cell and tissue preparations in a
variety of contexts leave much scope for considering Replacement.
Other options, such as the use of human volunteers (e.g. Halsey
et al., 2017), human samples or modelling of existing data sets, may
avoid animal use. However, it is crucially important that when
animals are used, the species chosen is relevant to the question being
addressed; the careful choice of model underpins the utility of the
scientific outcomes from any study. Therefore, Relevance could be
considered as a fourth R. The importance of Relevance is
highlighted by scientists who, for example, interrogate questions
at the species-specific level, particularly where adult forms cannot
be replaced by juveniles. In this situation, Replacement is not an R
that can be deployed. In turn, Refinement and Reduction become all
the more important levers to pull in seeking to maximise the health
and welfare of the experimental animals.
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